BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 4, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for March 14, 2023

March 14, 2023
New hires and promotions in the med-tech industry, including: CN Bio, Mindera Health, Tactile Systems Technology, Think Surgical, Visibly.
Read More

Regulatory actions for March 14, 2023

March 14, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acadia, Mersana.
Read More

Other news to note for March 14, 2023

March 14, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cingulate, Horizon, Indegene, Nuvo, Olatec, Oryzon, Searchlight.
Read More

In the clinic for March 14, 2023

March 14, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alx, Alzecure, Aridis, Asahi, Biothera, Biovie, Boan, Calliditas, Gensight, Isotope, Luye, Pliant, Vectivbio.
Read More

Financings for March 14, 2023

March 14, 2023
Biopharmas raising money in public or private financings, including: Adamis, Algotx, Betterlife, Okyo, Switch.
Read More

Appointments and advancements for March 14, 2023

March 14, 2023
New hires and promotions in the biopharma industry, including: Biogen, Bryn, Clearmind, Crispr, DEM, Leo.
Read More

Med-tech gainers and losers for March 6-10, 2023

March 13, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Regulatory actions for March 13, 2023

March 13, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: PADM Medical.
Read More

Other news to note for March 13, 2023

March 13, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Dnanudge, Mylab Discovery, Noah Medical, Occlutech.
Read More

In the clinic for March 13, 2023

March 13, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Terumo.
Read More
Previous 1 2 … 830 831 832 833 834 835 836 837 838 … 1789 1790 Next

Popular Stories

  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Alceptor Therapeutics discovers new α2B-adrenoceptor agonists

    BioWorld Science
    Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
  • Glucagon-like peptide-1 receptor (GLP-1R) complex

    Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control

    BioWorld
    A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
  • EQ-504 is AhR agonist for ulcerative colitis, related disorders

    BioWorld Science
    Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
  • Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers

    BioWorld Science
    Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing